Journal profile · Medicine-Infectious Diseases
Frontiers in Allergy
ISSN 2673-6101 · Frontiers Media S.A. · Switzerland
Frontiers in Allergy: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.4 (journal website); fully open access; APC charged, amount not published; median 51 days to acceptance (111 articles, last 24 months); 207 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Frontiers in Allergy is published by Frontiers Media S.A. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Allergic Rhinitis and Sensitization, Asthma and respiratory diseases and Food Allergy and Anaphylaxis Research, together about 50.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Allergy is a multidisciplinary journal that focuses on the mechanisms and causes of allergy as well as the management of allergic diseases, from precision to real-life medicine, spanning both childhood and adulthood. Led by Field Chief Editor Prof Nikolaos (Nikos) G Papadopoulos (Universities of Athens, Greece), Frontiers in Allergy welcomes research contributions in all domains of allergy that bridge the gap between scientific knowledge and practical applications. Frontiers in Allergy serves as a platform embracing diversity and communicating it to the wide audiences it affects. All areas of allergy are covered, from basic to clinical science, including organ and/or disease-specific perspectives and mechanistic and etiological aspects. Topics include but are not limited to: asthma drug allergy environmental determinants food allergy rhinitis skin allergies therapeutic targets. Randomized trials and real-life designs are equally welcome, as well as evidence synthesis and narrative reviews. All human studies must conform to the current regulations. Pre-registration of clinical studies in a relevant repository is highly recommended. In particular, the journal welcomes submissions which support and advance the UN’s Sustainable Development Goals (SDG), notably SDG 3: good health and well-being. The journal is indexed in PubMed Central (PMC), Web of Science Emerging Sources Citation Index (ESCI), Scopus and the DOAJ. Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not adhering to these standards will not be considered. Frontiers in Allergy is committed to advancing developments in the field of allergy by providing unrestricted access to articles and communicating scientific knowledge to researchers and the public. The journal aims to enable the scientific breakthroughs of the future and contribute to the improvement of human health. Frontiers in Allergy is a member of the Committee on Publication Ethics.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Infectious Diseases
Editorial board by country: none in mainland China; most named United States 3, Austria 3, Spain 2, Malaysia 2, United Kingdom 1 (17 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Allergic Rhinitis and SensitizationMedicine18.1%
- Asthma and respiratory diseasesMedicine17.8%
- Food Allergy and Anaphylaxis ResearchMedicine14.6%
- Dermatology and Skin DiseasesMedicine5.6%
- Drug-Induced Adverse ReactionsMedicine4.2%
- Sinusitis and nasal conditionsMedicine4.1%
- Contact Dermatitis and AllergiesMedicine3.7%
- Eosinophilic EsophagitisMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Allergy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Allergy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.4Publisher website ·
- CiteScore 2026-06
- 4.3LetPub ·
- CiteScore (publisher)
- 4.3Publisher website ·
- SJR 2026-06
- 0.87LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 35OpenAlex ·
- i10-index
- 257OpenAlex ·
- 2-year mean citedness
- 2.65OpenAlex ·
- Self-citation rate
- 5.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 179LetPub ·
Articles by year OpenAlex count · 987 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 219 | 219 | 100 |
| 2025 | 207 | 207 | 647 |
| 2024 | 148 | 148 | 775 |
| 2023 | 153 | 153 | 1,650 |
| 2022 | 153 | 153 | 2,388 |
| 2021 | 103 | 103 | 2,078 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
51 daysMedian, submission to acceptance · P25–P75 37 days – 79 days
- Acceptance to online
- median 20 days (111 articles)
- Submission to online
- median 78 days
- Sample
- 111 articles with submission and acceptance dates (468 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 2,550 | Yes | CC BY | |
| OpenAlex | CHF 2,550 | — | — | |
| LetPub | USD 2,125 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- 5–8
- Reference style
- Harvard
- Templates
- LaTeX and Word
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Peer review
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- License & copyright Open access and copyright
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Peer review Peer review
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2673-6101
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Allergy
What CAS zone is Frontiers in Allergy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Frontiers in Allergy is in Zone 3 of Medicine, and in Zone 4 of the minor category Allergy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Frontiers in Allergy?
The journal's website gives an impact factor of 3.4; this is the journal's own figure, as LetPub lists none for it; CiteScore 4.3, h-index 35.
How long does peer review take at Frontiers in Allergy?
Based on the dates recorded on 111 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 51 days (interquartile range 37–79 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Frontiers in Allergy?
According to the journal's author guidelines: Keywords: 5–8; Reference style: Harvard; Templates: LaTeX and Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Frontiers in Allergy based?
Of the 17 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (3), Austria (3) and Spain (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Frontiers in Allergy?
According to LetPub and DOAJ records, Frontiers in Allergy is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and PMC; that list has not been checked against each database.
Is Frontiers in Allergy open access, and what is the APC?
Frontiers in Allergy is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .